NASDAQ:ASMB Assembly Biosciences Q3 2026 Earnings Date & Estimates $20.09 -0.48 (-2.33%) Closing price 10/16/2026 04:00 PM EasternExtended Trading$20.12 +0.03 (+0.15%) As of 10/16/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Assembly Biosciences is estimated to report Q3 2026 earnings on Monday, November 9, 2026, after market closes. The conference call is scheduled for November 6, 2026 at 4:00 PM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ3 2026Announcement DateNovember 9, 2026TimeAfter Market ClosesConference Call DateNovember 6, 2026Conference Call4:00 PM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from Assembly Biosciences in Q3 2026Assembly Biosciences is expected to post earnings of -$0.6550 per share on revenue of $9.07 million. In the same quarter a year earlier Assembly Biosciences reported -$0.72 per share on revenue of $10.79 million. Assembly Biosciences last reported on August 13, 2026, posting -$0.20 per share and beating the -$0.7242 consensus estimate. Assembly Biosciences has beaten the consensus EPS estimate in 7 of its last 8 quarters.Consensus EstimatesConsensus EPS-$0.6550Expected Revenue$9.07 millionPrior-Year EPS-$0.72Prior-Year Revenue$10.79 millionExpected Revenue Growth-15.9%Recent Track RecordLast ReportedQ2 2026Last Quarter EPS-$0.20 (Beat by +$0.5242)Last Quarter Revenue$13.37 millionEPS Beat Rate7 of last 8 quartersPrepare for the Q3 2026 CallEarnings HistoryCompany ProfileQ2 2026 Earnings ReportQ1 2026 Earnings ReportQ4 2025 Earnings Report Assembly Biosciences Q3 2026 Earnings FAQ When does Assembly Biosciences report Q3 2026 earnings? Assembly Biosciences (NASDAQ:ASMB) is estimated to report Q3 2026 earnings on Monday, November 9, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it. What time is Assembly Biosciences' Q3 2026 earnings call? Assembly Biosciences' Q3 2026 earnings conference call is scheduled for Friday, November 6, 2026 at 4:00 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for Assembly Biosciences? Analysts expect Assembly Biosciences to post earnings of -$0.6550 per share for Q3 2026. How much revenue is Assembly Biosciences expected to report? The consensus revenue estimate for Assembly Biosciences is $9.07 million for Q3 2026. Assembly Biosciences Earnings HeadlinesAssembly Biosciences, Inc. Presents Positive Phase 1a Safety, Tolerability And Target Engagement Data For ABI-6250 At AASLD The Liver MeetingOctober 6, 2026 | marketscreener.comMAssembly Biosciences Plans to Present Posters Featuring New Phase 1a Data From ABI-6250 ProgramOctober 6, 2026 | finance.yahoo.comFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each warning issued before the crisis hit. Now the founder of Weiss Ratings, the only conflict-free rating agency in America, says he is watching a $3 trillion problem that could trigger a chain reaction across markets and banks.October 18 at 1:00 AM | Weiss Ratings (Ad)Assembly Biosciences to Present Positive Phase 1a Safety, Tolerability and Target Engagement Data for ABI-6250 at AASLD The Liver Meeting® 2026October 5, 2026 | globenewswire.comAssembly Biosciences (ASMB) Receives a Buy from Mizuho SecuritiesSeptember 12, 2026 | theglobeandmail.comAssembly Biosciences to Present at the H.C. Wainwright & Co. 28th Annual Global Investment ConferenceSeptember 10, 2026 | markets.businessinsider.comSee More Assembly Biosciences Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Assembly Biosciences? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Assembly Biosciences and other key companies, straight to your email. Email Address About Assembly BiosciencesAssembly Biosciences (NASDAQ:ASMB) is a clinical-stage biotechnology company focused on developing oral therapeutics for serious viral diseases. The company’s research programs target viral replication and other essential processes, with an emphasis on treatments that may improve outcomes for patients with limited therapeutic options. Assembly’s pipeline has included investigational therapies for chronic hepatitis B virus (HBV) infection, including core or capsid assembly modulators designed to interfere with the virus’s life cycle. The company is also developing oral helicase-primase inhibitors for herpesvirus infections, including herpes simplex virus (HSV), with programs intended to address recurrent or difficult-to-treat disease. The company was founded in 2005 and is headquartered in South San Francisco, California. Assembly has advanced its programs through internal research and strategic collaboration, including a relationship with Gilead Sciences focused on developing novel antiviral medicines. Its products remain investigational and are subject to clinical testing and regulatory review.View Assembly Biosciences ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 10/12 - 10/16Could a Trucking Squeeze Become J.B. Hunt’s Biggest Edge?Bank of America Stock Sell-Off Looks Like a Buying OpportunityManpowerGroup Stock Sinks on Q3 Results, But Fundamentals Stay SolidMorgan Stanley Beats on Earnings, But Shares Fall on Trading MixFundamental and Technicals Signals Align for Costco: Is the Stock Finally Breaking Out?These 2 Gold Miners Just Flashed Golden Crosses—Is a Breakout Coming? Upcoming Earnings America Movil (10/20/2026)Netflix (10/20/2026)General Motors (10/20/2026)Chubb (10/20/2026)Capital One Financial (10/20/2026)Intuitive Surgical (10/20/2026)GE Aerospace (10/20/2026)3M (10/20/2026)Northrop Grumman (10/20/2026)RTX (10/20/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
